Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
Sarwar Alam Chaudhary Registered Pharmacist, BHMS Scholar Reviewed Official Prescribing Label Warning Tirzepatide (Mounjaro / Zepbound) can cut oral birth control absorption by ~60% The manufacturers own label recommends switching to a non-oral contraceptive, or adding a barrier method, for 4 weeks after starting tirzepatide and after every dose increase
And guess what, David
Importantly, their cohort had slightly higher baseline BMI in the GLP-1 RA group (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide, mean ~ 42 vs
Hazen, M.D., Ph.D., senior author of the study and section head of Preventive Cardiology & Rehabilitation at the Cleveland Clinic